We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.12%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$13.2B
AUM Growth
+$1.19B
Cap. Flow
+$398M
Cap. Flow %
3.01%
Top 10 Hldgs %
25.15%
Holding
2,888
New
90
Increased
233
Reduced
1,480
Closed
57

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$33.4M
2
AAPL icon
Apple
AAPL
+$20.4M
3
MSFT icon
Microsoft
MSFT
+$10.9M
4
TWTR
Twitter, Inc.
TWTR
+$9.15M
5
Y
Alleghany Corp
Y
+$7.32M

Sector Composition

Rank Sector Weight
1 Technology 19.63%
2 Healthcare 13.34%
3 Financials 12.1%
4 Consumer Discretionary 9.16%
5 Industrials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YEXT icon
1801
Yext
YEXT
$574M
$393K ﹤0.01%
60,219
PAR icon
1802
PAR Technology
PAR
$741M
$392K ﹤0.01%
15,029
AGNT
1803
AGNT Inc
AGNT
$715M
$391K ﹤0.01%
35,271
ARR
1804
Armour Residential REIT
ARR
$2.37B
$389K ﹤0.01%
13,830
+3,066
+28% +$83.7K
PCT icon
1805
PureCycle Technologies
PCT
$1.44B
$388K ﹤0.01%
57,403
VREX icon
1806
Varex Imaging
VREX
$778M
$387K ﹤0.01%
19,076
SXC icon
1807
SunCoke Energy
SXC
$801M
$387K ﹤0.01%
44,813
PENG
1808
Penguin Solutions Inc
PENG
$3.12B
$387K ﹤0.01%
25,987
DLX icon
1809
Deluxe
DLX
$1.09B
$387K ﹤0.01%
22,763
MNTK icon
1810
Montauk Renewables
MNTK
$265M
$386K ﹤0.01%
35,015
FDMT icon
1811
4D Molecular Therapeutics
FDMT
$621M
$386K ﹤0.01%
17,379
DCPH
1812
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$385K ﹤0.01%
23,468
WSC icon
1813
WillScot Mobile Mini Holdings
WSC
$4B
$384K ﹤0.01%
8,508
-361
-4% -$16.2K
IMVT icon
1814
Immunovant
IMVT
$8.8B
$384K ﹤0.01%
21,647
AGEN
1815
Agenus
AGEN
$315M
$384K ﹤0.01%
8,150
+856
+12% +$43.5K
NKLA
1816
DELISTED
Nikola Corporation Common Stock
NKLA
$384K ﹤0.01%
5,924
+347
+6% +$29K
NABL icon
1817
N-able
NABL
$695M
$383K ﹤0.01%
37,268
NFBK
1818
DELISTED
Northfield Bancorp
NFBK
$382K ﹤0.01%
24,262
FFWM
1819
DELISTED
First Foundation Inc
FFWM
$381K ﹤0.01%
26,604
TBPH icon
1820
Theravance Biopharma
TBPH
$878M
$381K ﹤0.01%
33,942
CRNC icon
1821
Cerence
CRNC
$391M
$381K ﹤0.01%
20,536
PLYM
1822
DELISTED
Plymouth Industrial REIT
PLYM
$380K ﹤0.01%
19,829
+575
+3% +$10.9K
GOGO icon
1823
Gogo Inc
GOGO
$383M
$380K ﹤0.01%
25,722
SQSP
1824
DELISTED
Squarespace, Inc.
SQSP
$379K ﹤0.01%
17,116
GOOD
1825
Gladstone Commercial Corp
GOOD
$630M
$379K ﹤0.01%
20,482
+101
+0.5% +$1.8K

Similar funds

MetLife Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, MetLife Investment Management held 2,888 positions worth $13.2B, up 9.9% from $12B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management deployed $398M of net new capital in Q4 2022, opening 90 new positions and adding to 233 existing holdings. Its largest new stake was Atlassian: 8,691 shares worth $1.12M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $33.4M trimmed.

  • MetLife Investment Management's largest Q4 2022 buy was Atlassian: 8,691 shares worth $1.12M.
  • MetLife Investment Management added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2022, an estimated $651M increase.
  • MetLife Investment Management's biggest Q4 2022 reduction was iShares MSCI EAFE ETF, cutting an estimated $33.4M.
  • MetLife Investment Management fully exited Twitter, Inc. in Q4 2022, selling an estimated $9.15M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $13.2B portfolio in Q4 2022.
  • MetLife Investment Management opened 90 new positions and closed 57 in Q4 2022.
  • MetLife Investment Management's portfolio value rose 9.9% quarter-over-quarter to $13.2B.

Based on MetLife Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.